DK433087D0 - Monoklonale antistoffer og peptider, der kan anvendes til behandling og diagnose af hiv-infektioner - Google Patents

Monoklonale antistoffer og peptider, der kan anvendes til behandling og diagnose af hiv-infektioner

Info

Publication number
DK433087D0
DK433087D0 DK433087A DK433087A DK433087D0 DK 433087 D0 DK433087 D0 DK 433087D0 DK 433087 A DK433087 A DK 433087A DK 433087 A DK433087 A DK 433087A DK 433087 D0 DK433087 D0 DK 433087D0
Authority
DK
Denmark
Prior art keywords
peptides
diagnosis
treatment
monoclonal antibodies
hiv infections
Prior art date
Application number
DK433087A
Other languages
English (en)
Other versions
DK433087A (da
Inventor
Mary Katleen Shriver
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Janela Nmi Mcclure
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of DK433087D0 publication Critical patent/DK433087D0/da
Publication of DK433087A publication Critical patent/DK433087A/da

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK433087A 1986-08-20 1987-08-19 Monoklonale antistoffer og peptider, der kan anvendes til behandling og diagnose af hiv-infektioner DK433087A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (2)

Publication Number Publication Date
DK433087D0 true DK433087D0 (da) 1987-08-19
DK433087A DK433087A (da) 1988-02-21

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK433087A DK433087A (da) 1986-08-20 1987-08-19 Monoklonale antistoffer og peptider, der kan anvendes til behandling og diagnose af hiv-infektioner

Country Status (28)

Country Link
JP (1) JPS6485928A (da)
KR (1) KR920008744B1 (da)
AT (1) AT398080B (da)
AU (1) AU616156B2 (da)
BE (1) BE1000811A4 (da)
CH (1) CH675728A5 (da)
CS (1) CS275838B6 (da)
DE (1) DE3727703A1 (da)
DK (1) DK433087A (da)
ES (1) ES2010727A6 (da)
FI (1) FI873553A (da)
FR (1) FR2603107B1 (da)
GB (1) GB2196634B (da)
GR (1) GR871298B (da)
HU (1) HU214439B (da)
IE (1) IE60671B1 (da)
IL (1) IL83580A (da)
IT (1) IT1222518B (da)
LU (1) LU86972A1 (da)
NL (1) NL8701950A (da)
NO (2) NO300462B1 (da)
NZ (1) NZ221440A (da)
OA (1) OA08652A (da)
PL (1) PL155084B1 (da)
PT (1) PT85567B (da)
SE (1) SE506025C2 (da)
YU (1) YU152587A (da)
ZW (1) ZW15487A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
AU621097B2 (en) * 1988-01-26 1992-03-05 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2025481A1 (en) * 1989-09-19 1991-03-20 Peter J. Kniskern Vaccine for aids and hepatitis b
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
WO1993020102A1 (en) * 1992-03-27 1993-10-14 Peptide Technology Limited Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
DK1976548T3 (da) 2005-12-09 2014-10-06 Vectus Biosystems Ltd VIP-fragmenter og sammensætninger deraf
JP5165751B2 (ja) 2008-09-02 2013-03-21 日本特殊陶業株式会社 スパークプラグ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE122005000039I1 (de) * 1984-10-18 2006-02-23 Pasteur Institut DNS-Fragmente des GAG-Gens von LAV
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
JP2837669B2 (ja) * 1985-11-07 1998-12-16 プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ Ｔ−細胞リンパ趨行性ウイルス蛋白及びその分析
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
WO1988005051A1 (en) * 1986-12-30 1988-07-14 United States Of America, Represented By The Unite Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins

Also Published As

Publication number Publication date
IE872219L (en) 1988-02-20
LU86972A1 (fr) 1988-03-02
NO934897L (no) 1993-12-29
FI873553A (fi) 1988-02-21
GR871298B (en) 1988-01-12
DE3727703A1 (de) 1988-05-05
NZ221440A (en) 1991-11-26
NO934897D0 (no) 1993-12-29
FI873553A0 (fi) 1987-08-17
PT85567B (pt) 1991-02-08
GB2196634B (en) 1991-05-15
AU616156B2 (en) 1991-10-24
FR2603107B1 (fr) 1992-04-24
PL267401A1 (en) 1988-07-21
IT1222518B (it) 1990-09-05
GB2196634A (en) 1988-05-05
NO300462B1 (no) 1997-06-02
KR890002547A (ko) 1989-04-10
CS8706136A2 (en) 1990-08-14
PL155084B1 (en) 1991-10-31
ZW15487A1 (en) 1988-09-14
AU7720187A (en) 1988-05-19
KR920008744B1 (ko) 1992-10-09
CS275838B6 (en) 1992-03-18
CH675728A5 (da) 1990-10-31
SE506025C2 (sv) 1997-11-03
NO302176B1 (no) 1998-02-02
OA08652A (fr) 1988-11-30
DK433087A (da) 1988-02-21
HUT44619A (en) 1988-03-28
IL83580A (en) 1992-11-15
JPS6485928A (en) 1989-03-30
YU152587A (sh) 1992-09-07
IE60671B1 (en) 1994-08-10
NO873495D0 (no) 1987-08-19
SE8703225L (sv) 1988-02-21
IL83580A0 (en) 1988-01-31
HU214439B (hu) 1998-03-30
PT85567A (en) 1987-09-01
ES2010727A6 (es) 1989-12-01
NO873495L (no) 1988-02-22
BE1000811A4 (fr) 1989-04-11
NL8701950A (nl) 1988-03-16
ATA208987A (de) 1994-01-15
SE8703225D0 (sv) 1987-08-19
IT8721678A0 (it) 1987-08-19
FR2603107A1 (fr) 1988-02-26
AT398080B (de) 1994-09-26
GB8719587D0 (en) 1987-09-23

Similar Documents

Publication Publication Date Title
DK433087A (da) Monoklonale antistoffer og peptider, der kan anvendes til behandling og diagnose af hiv-infektioner
DK157361C (da) Fremgangsmaade til fremstilling af titanmodificeret poroest, krystallinsk siliciumoxid og anvendelse af dette.
DK625987D0 (da) Lysinsalt af gadolinium-dota kompleks og dets diagnostiske anvendelser
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK489787A (da) Hidtil ukendte glycopeptid-antibiotika hoerende til vancomycin-gruppen og fremgangsmaade til fremstilling af saadanne antibiotika
DK59778A (da) Fremgangsmaade til fremstilling af antigen og antistof
DK557477A (da) Fremgangsmaade til fremstilling af gammaglobuliner immun-nucleinsyrer og immum-dialysater
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DK78183A (da) Antistoffer og antigener, der er nyttige til diagnose og behandling af cancer
NO883834D0 (no) Fremgangsmaate for fremstilling av nye hiv-proteiner og peptider.
DK419287D0 (da) Fremgangsmaade til fremstilling og anvendelse af faste, fytoaktive midler
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK513687D0 (da) Monoklonale antistoffer over for ifn-omega, fremgangsmaade til deres fremstilling og deres anvendelse til rensning samt paavisning af ifn-omega
DK482583D0 (da) Dna-sekvens, dna-strukturer og fremgangsmade til fremstilling af penicillin-acylase under anvendelse deraf
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK410888A (da) Monoklonale antistoffer og diagnosefremgangsmaade for phytophthora-infektioner
DK169489A (da) Fast baerer til immunologisk diagnostik, fremgangsmaade til behandling af en saadan baerer og anvendelse af baereren til immunologisk diagnostik
DK122185D0 (da) Fremgangsmaader, forbindelser og midler til behandling af protozo-infektioner
NO871484L (no) Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider.
IT8719010A0 (it) Procedimento di trattamento dimateriali filtranti usati.
DK494084A (da) Hybridoma, monokloniske antistoffer frembragt hermed og diagnosemetode under anvendelse af disse
DK149620C (da) Fremgangsmaade til adskillelse af blod opdelt i serum og sedimentat og apparat til brug herved
DE3776779D1 (de) Digitales rang-groessenordnungsfilter und dementsprechendes verfahren.
DK589586D0 (da) Ekspression og diagnostisk anvendelse af gag-kodede peptider, der erimmunologisk reaktive med antistoffer til lav
DK542986A (da) Fremgangsmaade til afsloering af proteiner og vira og diagnosesaet til udoevelse af fremgangsmaaden

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment